Skip to content

Roivant Sciences ROIV Accounts Payable

Accounts Payable at other companies

Amgen logo
AmgenAMGN
$2.94B+22.0%
Moderna logo
ModernaMRNA
$161M-28.8%
Immunovant, Inc. logo
Immunovant, Inc.IMVT
$7.54M-57.3%
Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$4.23B+5.8%
Regenxbio logo
RegenxbioRGNX
$21.21M+11.4%
Revvity logo
RevvityRVTY
$169.68M-4.7%

Other financials

Income statement

See full
Revenue$2.5M-66.7%
Operating income-$339.2M-23.6%
Net income-$265.9M-257%
EPS (diluted)-$0.38-265%

Balance sheet

See full
Cash & equivalents$1.4B+1,411%
Total debt$107.4M+7.3%
Total equity$4.5B-3.4%
Total assets$5.7B+5.0%

Cash flow

See full
Operating cash flow-$163.8M+5.1%
CapEx$1.3M+55.5%
Free cash flow-$165.1M+4.8%

Valuation

See full
Market cap$25.25B+226%
Enterprise value$23.93B+209%
P/S3,056.5×+2,723×

Profitability

See full
Operating margin-9,130.5%-13,995pp
Net margin-6,079.9%-6,193pp
FCF margin-9,183.5%-17,093pp

Returns & leverage

See full
Return on equity-17.1%-17.7pp
Debt / equity0.0×
Current ratio18.4×-15.1×

Where this comes from

Reported directly by Roivant Sciences in its filing.

Tagged under the XBRL concept us-gaap:AccountsPayableCurrent.

The official record: Roivant Sciences’s 10-K, filed May 20, 2026, on SEC EDGAR. View the filing →

Ask your AI about Roivant Sciences's accounts payable.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Roivant Sciences's accounts payable?
Roivant Sciences (ROIV) reported accounts payable of $18M in Q1 2026.
How has Roivant Sciences's accounts payable changed year-over-year?
Roivant Sciences's accounts payable decreased by 24.0% year-over-year, from $23.69M to $18M.
What is the long-term trend for Roivant Sciences's accounts payable?
Over 5 years (2020 to 2025), Roivant Sciences's accounts payable has grown at a -2.6% compound annual growth rate (CAGR), from $20.55M to $18M.
What does accounts payable mean?
Amounts owed to suppliers and vendors for goods and services received but not yet paid. A primary source of short-term trade financing.